Explore

UC San Diego Researchers Develop AI-Powered Virtual Cells to Accelerate Drug Discovery

UC San Diego Researchers Develop AI-Powered Virtual Cells to Accelerate Drug Discovery

Researchers at UC San Diego have developed an advanced imaging technique to create high-fidelity 4D movies of human cells, leading to the creation of virtual cells and an AI model named MitoSpace. This technology allows scientists to predict how mitochondria within human cells will respond to drug treatments. The team created a physics-based 'digital twin' of a real cancer cell, mapping the positions of mitochondria and their microtubule tracks, and incorporating motor proteins and laws of motion. This virtual cell's parameters were adjusted to match the behavior of real cells. Additionally, they trained MitoSpace using 40,000 single-cell 4D movies from cancer cells treated with 25 different compounds. Unlike traditional AI models, MitoSpace independently identified patterns in mitochondrial behavior, enabling it to group cells with similar responses and predict their energetic states based solely on mitochondrial shape and movement across various drug conditions. This approach achieved 75% accuracy in dis...

Time-Restricted Eating Shows Promise in Slowing Early-Stage Huntington's Disease Progression

Time-Restricted Eating Shows Promise in Slowing Early-Stage Huntington's Disease Progression

A 12-week pilot study led by Oregon Health & Science University (OHSU) has found that time-restricted eating, a form of intermittent fasting, may help slow the progression of early-stage Huntington's disease. Participants in the study limited their food consumption to a six-to-eight-hour window daily, successfully maintaining their weight and lean muscle mass. The research, published in Nature Metabolism, is the first clinical study to investigate time-restricted eating in individuals with Huntington's disease. Key findings include an average improvement of 0.5 points on the composite Unified Huntington's Disease Rating Scale (cUHDRS), a measure of disease severity that typically declines annually. Additionally, blood levels of neurofilament light, a biomarker indicating nerve cell damage, decreased by an average of 13%, a reversal of the expected increase as the disease progresses. Researchers also observed improvements in mitochondrial activity, which is crucial for cellular energy production and often i...

Oregon Health Science University Study Shows Intermittent Fasting May Slow Huntington's Disease Progression

Oregon Health Science University Study Shows Intermittent Fasting May Slow Huntington's Disease Progression

A 12-week pilot study conducted by Oregon Health & Science University (OHSU) indicates that time-restricted eating, a form of intermittent fasting, may offer a promising approach to slowing the progression of Huntington's disease. The study, published in Nature Metabolism, involved people with early-stage Huntington's disease who limited their food consumption to a six-to-eight-hour window daily. Participants successfully adhered to the eating schedule, maintained their body weight and lean muscle mass, and reported few side effects. Researchers observed improvements in measures of disease severity, a reduction in a blood biomarker linked to nerve cell damage (neurofilament light), and enhanced cellular energy production. This marks the first clinical study to investigate time-restricted eating in individuals with Huntington's disease, a rare, inherited neurological disorder that progressively damages nerve cells.

University of North Carolina Researchers Develop New fMRI Technique for Enhanced Brain Mapping

University of North Carolina Researchers Develop New fMRI Technique for Enhanced Brain Mapping

Researchers at the University of North Carolina at Chapel Hill (UNC-CH) have developed a new functional magnetic resonance imaging (fMRI) technique called SORDINO. This innovative method aims to improve brain mapping during behavior by addressing limitations of conventional fMRI approaches. Traditional fMRI, which detects blood-oxygenation-level-dependent (BOLD) signals, can be noisy, imprecise, and sensitive to movement and magnetic field distortions. SORDINO, inspired by the musical term 'con sordino' meaning 'with a mute,' ensures that the overall strength of an MRI scanner's magnetic gradients remains almost constant while smoothly changing direction. This continuous signal collection avoids the abrupt gradient switching that makes conventional fMRI sequences noisy and vulnerable to interference. The technique has been successfully used to map brain-wide activity in rodents performing behavioral tasks, demonstrating better sensitivity than the gold standard gradient-echo EPI at matched spatiotemporal r...

Researchers Develop Part-Human, Part-Mouse Brains for Disease Study, Raising Ethical Questions

Researchers Develop Part-Human, Part-Mouse Brains for Disease Study, Raising Ethical Questions

Recent advancements in neuroscience have led to the creation of part-human, part-mouse brains. Researchers have genetically engineered mice to lack their own cerebral cortex and subsequently implanted human brain cells into these mice. This innovative approach aims to provide a more accurate model for studying human-specific psychiatric and neurodevelopmental diseases, which are difficult to research using traditional animal models or lab-grown organoids alone. The human cells are integrated into the mouse brain, forming connections and developing in a more natural environment than a petri dish. This method allows scientists to observe how human neurons function and interact within a living system, offering new insights into complex brain conditions.

IISc Scientists Control Human Cell Division with Blue Light, Bypassing Natural Scaffolding

IISc Scientists Control Human Cell Division with Blue Light, Bypassing Natural Scaffolding

Researchers at the Indian Institute of Science (IISc) in Bengaluru have developed a method to control human cell division using flashes of blue light. This technique, named Light-Induced Spindle Assembly (LISA), allows scientists to trigger the assembly of the microscopic machinery required for cell division by clustering Aurora A proteins. This is achieved by engineering human cells to attach Aurora A proteins to a light-sensitive module. When blue light is applied, these proteins rapidly clump together, activating them and initiating the formation of the mitotic spindle, which is crucial for DNA division. This breakthrough demonstrates that the massive Cep192 scaffold, previously thought necessary for Aurora A activation, is not essential. The LISA system can even rescue cells from division failure when their centrosomes, the natural organizers of microtubule threads, are intentionally destroyed. Unlike previous methods, LISA operates directly within living human cells and is fully reversible, allowing f...

Pancreatic Cancer Action Network Funds Research and Ensures Public Access to Findings

Pancreatic Cancer Action Network Funds Research and Ensures Public Access to Findings

The Pancreatic Cancer Action Network (PanCAN) is actively funding grants for basic, translational, and clinical research to accelerate advancements in understanding, preventing, detecting, treating, and curing pancreatic cancer. These grants are offered to scientists and clinicians at various career levels. PanCAN's Scientific and Medical Affairs team conducts independent and collaborative research as part of its strategic approach to increase survival rates for pancreatic cancer patients. A key component of PanCAN's strategy is its Public Access Publication Policy, which mandates that researchers receiving their grants publish their findings in peer-reviewed journals. To ensure broad accessibility, these published manuscripts are then made publicly available through the National Institutes of Health's PubMed Central (PMC). PanCAN also advocates for the use of the free Open Science Framework (OSF) to enhance transparency, foster collaboration, and increase the visibility of research.

Sokolove Law Donates to Providence Cancer Institute for Mesothelioma Research and Patient Care

Sokolove Law Donates to Providence Cancer Institute for Mesothelioma Research and Patient Care

Sokolove Law, a national mesothelioma law firm, has made a $2,500 donation to the Providence Cancer Institute in Portland, Oregon. This contribution is intended to support cancer research and mesothelioma care at the institute. The donation was specifically made to the Shell-Shocked Sprinters, a Hood to Coast Relay team that includes Sokolove Law Registered Nurse Andi Lowe. Providence Cancer Institute has been the primary charitable beneficiary of the Hood to Coast and Portland to Coast relays since 2013. Philanthropy accounts for approximately 70% of the institute's cancer research funding, including its thoracic oncology program, which specializes in treating mesothelioma. The Shell-Shocked Sprinters successfully completed the 196-mile relay, contributing to the event's overall fundraising of over $1 million this year, bringing the cumulative total to more than $10.5 million, all of which remains in Oregon to fund cancer research, treatment, and patient support services.

NIH-Funded Research Reveals GLP-1 Drug Slows Aging and Extends Lifespan in Mice

NIH-Funded Research Reveals GLP-1 Drug Slows Aging and Extends Lifespan in Mice

A research team funded by the National Institutes of Health (NIH), led by Dr. Danica Chen at the University of California, Berkeley, has found that a GLP-1 drug, semaglutide, slows aging and extends the lifespan in older female mice. The study, published in Nature, involved treating 20-month-old female mice daily with semaglutide for three months, resulting in improved muscular and cognitive function, coordination, balance, and endurance compared to a control group. These treated mice also lived approximately 100 days longer than untreated mice. The researchers compared semaglutide's effects to calorie restriction and found that while both prevented age-related declines, semaglutide uniquely improved exploratory behavior, spatial memory, and glucose tolerance, suggesting different underlying mechanisms.

Scientists Develop Nasal Spray H5N1 Vaccine Showing Promise in Mice Against Bird Flu

Scientists Develop Nasal Spray H5N1 Vaccine Showing Promise in Mice Against Bird Flu

Scientists have developed an experimental nasal spray vaccine for the H5N1 avian influenza virus, demonstrating significant protection in mice. The vaccine, which uses a modified vesicular stomatitis virus (VSV) as a carrier to deliver H5N1-related material, was administered in two doses four weeks apart. Following exposure to a lethal strain of H5N1, all vaccinated mice survived, while unvaccinated control animals did not. Researchers observed a dramatic reduction in viral load, with approximately 100,000 times less virus found in the nasal and tracheal tissues of vaccinated mice compared to unvaccinated ones. This approach aims to stimulate mucosal immunity, providing a localized defense at the respiratory surfaces where the virus typically enters the body, rather than relying solely on systemic immunity. The protection offered by the vaccine was also found to be durable, lasting for months in the tested animals.

Salk Institute Researchers Create Microprotein Atlas Linking Brain Immune Cell Dysfunction to Alzheimer’s Disease

Salk Institute Researchers Create Microprotein Atlas Linking Brain Immune Cell Dysfunction to Alzheimer’s Disease

Researchers at the Salk Institute have developed the first microprotein atlas of the human frontal cortex, both with and without Alzheimer’s disease. This atlas, detailed in a study published in Nature Aging, integrates transcriptomics, mass spectrometry, and deep-learning-predicted spectra from postmortem brain samples to identify microproteins—small proteins typically 150 amino acids or fewer—that have been previously overlooked. The study identified 1,067 uncharacterized microproteins, some of which were expressed differently in Alzheimer’s disease samples, often showing higher overall microprotein expression. Specifically, the researchers focused on microglia, brain immune cells, and found a microprotein at the MKKS locus that was downregulated in Alzheimer’s disease. Knocking out the gene for this microprotein in microglia impaired mitochondrial respiration, suggesting its role in microglial bioenergetics and a potential link between microproteins and immune cell dysfunction in Alzheimer’s.

Oncogenomics Revolutionizes Cancer Treatment Decisions Through Genomic Analysis

Oncogenomics Revolutionizes Cancer Treatment Decisions Through Genomic Analysis

Oncogenomics is a specialized field focused on the genomic analysis of tumors to guide cancer treatment decisions. This approach involves studying mutations in oncogenes and tumor suppressor genes, which are critical in the transformation of healthy cells into malignant ones. By understanding these genetic alterations, oncogenomics plays a pivotal role in personalized medicine, allowing for treatments to be tailored to an individual's unique genetic profile. This customization aims to reduce adverse reactions and improve overall healthcare outcomes. The open-access journal Oncotarget actively publishes research across all aspects of oncology, highlighting the ongoing advancements and importance of this field in medical research and practice. Personalized medicine, which includes oncogenomics, has been gaining momentum since the Human Genome Project's completion in 2003, enabling rapid advancements in genetic testing to identify disease-associated mutations.